AIMEE LEWIS

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations; H.R. 8163/S. 5180, Provider Reimbursement Stability Act

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations

Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star Ratings

Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star ratings

H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations; H.R. 8163/S. 5180, Provider Reimbursement Stability Act

H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations; H.R. 8163/S. 5180, Provider Reimbursement Stability Act

H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026

H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star Ratings

Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star ratings

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations; H.R. 8163/S. 5180, Provider Reimbursement Stability Act

H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)

Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC); Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)

Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC); Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to innovation in Mediare payments

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to innovation in Mediare payments

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC); Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC)

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

H.R. 2484, Seniors Access to Critical Medications Act; Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

H.R. 2484, Seniors Access to Critical Medications Act; Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to the extension of telehealth services; Issues related to site neutral payments

Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.

Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.

Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

H.R. 2484, Seniors Access to Critical Medications Act; Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act

Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.

Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.

Issues relating to Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Expiring healthcare extenders; Issues related to the use of AI and its correlation to prior authorization and utilization management policies; S. 1105, No UPCODE Act

Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to innovation in Mediare payments

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC)

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC); Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC)

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to innovation in Mediare payments

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)

Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Issues related to Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Congressional briefing on SNP Supplemental Benefits; Expiring healthcare extenders; H.R. 10545, American Relief Act, 2025

Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 10545, American Relief Act, 2025; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 6860/S. 5018, the Restore Protections for Dialysis Patients Act; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 10545, American Relief Act, 2025

Telehealth extension; Issues related to site neutral payments; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

H.R. 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act; Access and reimbursement of Part B Drugs in Medicare; Continued expansion of Telehealth services including in H.R. 3875/S. 3967, Expanded Telehealth Access Act and Telehealth Modernization Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act (PATIENT Act) of 2023; H.R. 4822, Health Care Price Transparency Act of 2023; Support for site neutrality policies in H.R. 5378, Lower Costs, More Transparency Act; Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022; Issues related to MACRA Reform including H.R. 2474, Strengthening Medicare for Patients and Providers Act; Support the passage of H.R. 5526/S. 3458, the Seniors' Access to Critical Medications Act; H.R. 6683, Preserving Seniors Access to Physicians Act of 2023; Issues related to prior authorization in H.R. 8702/S. 4518, Improving Seniors Timely Access to Care Act of 2024

Telehealth extension; Issues related to site neutral payments; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act

H.R. 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act; Access and reimbursement of Part B Drugs in Medicare; Continued expansion of Telehealth services including in H.R. 3875/S. 3967, Expanded Telehealth Access Act and Telehealth Modernization Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act (PATIENT Act) of 2023; H.R. 4822, Health Care Price Transparency Act of 2023; Support for site neutrality policies in H.R. 5378, Lower Costs, More Transparency Act; Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022; Issues related to MACRA Reform including H.R. 2474, Strengthening Medicare for Patients and Providers Act; Support the passage of H.R. 5526/S. 3458, the Seniors' Access to Critical Medications Act; H.R. 6683, Preserving Seniors Access to Physicians Act of 2023; Issues related to prior authorization in H.R. 8702/S. 4518, Improving Seniors Timely Access to Care Act of 2024

H.R. 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act; Access and reimbursement of Part B Drugs in Medicare; Continued expansion of Telehealth services including in H.R. 3875/S. 3967, Expanded Telehealth Access Act and Telehealth Modernization Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act (PATIENT Act) of 2023; H.R. 4822, Health Care Price Transparency Act of 2023; Support for site neutrality policies in H.R. 5378, Lower Costs, More Transparency Act; Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022; Issues related to MACRA Reform including H.R. 2474, Strengthening Medicare for Patients and Providers Act; Support the passage of H.R. 5526/S. 3458, the Seniors' Access to Critical Medications Act; H.R. 6683, Preserving Seniors Access to Physicians Act of 2023; Issues related to prior authorization in H.R. 8702/S. 4518, Improving Seniors Timely Access to Care Act of 2024

Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)